Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells
Overview
Authors
Affiliations
Withaferin A (WA), a major bioactive component of the Indian herb Withania somnifera, induces cell death (apoptosis/necrosis) in multiple types of tumor cells, but the molecular mechanism underlying this cytotoxicity remains elusive. We report here that 2 μM WA induced cell death selectively in androgen-insensitive PC-3 and DU-145 prostate adenocarcinoma cells, whereas its toxicity was less severe in androgen-sensitive LNCaP prostate adenocarcinoma cells and normal human fibroblasts (TIG-1 and KD). WA also killed PC-3 cells in spheroid-forming medium. DNA microarray analysis revealed that WA significantly increased mRNA levels of c-Fos and 11 heat-shock proteins (HSPs) in PC-3 and DU-145, but not in LNCaP and TIG-1. Western analysis revealed increased expression of c-Fos and reduced expression of the anti-apoptotic protein c-FLIP(L). Expression of HSPs such as HSPA6 and Hsp70 was conspicuously elevated; however, because siRNA-mediated depletion of HSF-1, an HSP-inducing transcription factor, reduced PC-3 cell viability, it is likely that these heat-shock genes were involved in protecting against cell death. Moreover, WA induced generation of reactive oxygen species (ROS) in PC-3 and DU-145, but not in normal fibroblasts. Immunocytochemistry and immuno-electron microscopy revealed that WA disrupted the vimentin cytoskeleton, possibly inducing the ROS generation, c-Fos expression and c-FLIP(L) suppression. These observations suggest that multiple events followed by disruption of the vimentin cytoskeleton play pivotal roles in WA-mediated cell death.
Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers.
Cao P, Dominic A, Lujan F, Senthilkumar S, Bhattacharya P, Frigo D Nat Rev Urol. 2024; 21(10):615-637.
PMID: 38627553 DOI: 10.1038/s41585-024-00869-9.
Withaferin A and Celastrol Overwhelm Proteostasis.
Vilaboa N, Voellmy R Int J Mol Sci. 2024; 25(1).
PMID: 38203539 PMC: 10779417. DOI: 10.3390/ijms25010367.
Xing Z, Su A, Mi L, Zhang Y, He T, Qiu Y Drug Des Devel Ther. 2023; 17:2909-2929.
PMID: 37753228 PMC: 10519218. DOI: 10.2147/DDDT.S422512.
Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant (L.) Dunal.
Kumar S, Mathew S, Aharwal R, Tulli H, Mohan C, Sethi G Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259311 PMC: 9966696. DOI: 10.3390/ph16020160.
The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.
Abeesh P, Guruvayoorappan C Curr Mol Med. 2023; 24(4):404-418.
PMID: 37076466 DOI: 10.2174/1566524023666230418094708.